varenzin-CA1 Suspension
varenzin-CA1 is an FDA-approved preparation containing varenzin-CA1, for veterinary use. Available by prescription.
Molidustat, commercially available as Varenzin-CA1, is a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor utilized for feline anemia management. It is a prescription oral suspension requiring professional guidance from a licensed veterinarian. It is frequently considered in the context of kidney health for cats presented with anemia associated with chronic kidney disease (CKD).
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, it is used in the context of managing the body's natural production of erythropoietin (EPO) by mimicking a low-oxygen environment. Commonly observed effects include localized digestive changes such as vomiting or a decrease in appetite and behavioral shifts like lethargy. Because it influences red blood cell production, your veterinarian will monitor for observational signs of recovery through regular blood work (packed cell volume/PCV). Owners should monitor for significant changes in activity and contact their veterinarian promptly.
Yes. Varenzin-CA1 is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before Preparing any order.
Veterinarians discuss Varenzin-CA1 because it is a once-daily oral solution that signals the cat's own body to produce more red blood cells. This offers an approach to managing anemia associated with CKD.
Your veterinarian will recommend frequent blood tests to monitor red blood cell counts, especially when first starting. This monitoring ensures the management approach remains safe and suitable.
A decrease in appetite is a commonly observed effect. If you notice your cat is eating significantly less, contact your veterinarian for a clinical review of the management plan.
Varenzin-CA1 is typically authorized for specific management cycles. Your veterinarian will determine the necessary duration based on your cat’s clinical response and blood work results.
